CareDx (CDNA) Short Interest Ratio & Short Volume → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free CDNA Stock Alerts $7.56 0.00 (0.00%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability CareDx Short Interest DataCurrent Short Volume4,690,000 sharesPrevious Short Volume5,180,000 sharesChange Vs. Previous Month-9.46%Dollar Volume Sold Short$38.46 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 15, 2024Outstanding Shares51,780,000 sharesFloat Size49,140,000 sharesShort Percent of Float9.54%Today's Trading Volume492,900 sharesAverage Trading Volume888,126 sharesToday's Volume Vs. Average55% Short Selling CareDx ? Sign up to receive the latest short interest report for CareDx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCDNA Short Interest Over TimeCDNA Days to Cover Over TimeCDNA Percentage of Float Shorted Over Time Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. CareDx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,690,000 shares $38.46 million -9.5%9.5%5.3 $8.20 3/31/20245,180,000 shares $54.86 million +18.8%10.5%5.5 $10.59 3/15/20244,360,000 shares $44.21 million +16.0%8.8%4.5 $10.14 2/29/20243,760,000 shares $40.01 million +4.4%7.6%3.5 $10.64 2/15/20243,600,000 shares $30.60 million +26.3%7.0%3.4 $8.50 1/31/20242,850,000 shares $24.40 million +20.3%5.5%2.4 $8.56 Get the Latest News and Ratings for CDNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,370,000 shares $26.09 million +3.0%4.6%2 $11.01 12/31/20232,300,000 shares $27.60 million -27.0%4.5%1.9 $12.00 12/15/20233,150,000 shares $31.41 million -7.9%6.1%2.7 $9.97 11/30/20233,420,000 shares $33.21 million -12.1%6.6%3.2 $9.71 11/15/20233,890,000 shares $35.17 million -13.6%7.5%4.1 $9.04 10/31/20234,500,000 shares $24.35 million +10.6%8.7%5.4 $5.41 10/15/20234,070,000 shares $23.00 million +16.3%7.9%5.3 $5.65 9/30/20233,500,000 shares $24.50 million -10.3%6.8%4.7 $7.00 9/15/20233,900,000 shares $30.89 million -5.8%N/A4.7 $7.92 8/31/20234,140,000 shares $38.54 million +2.5%N/A4.5 $9.31 8/15/20234,040,000 shares $39.03 million -8.4%N/A4.4 $9.66 7/31/20234,410,000 shares $48.11 million -17.3%8.5%4.7 $10.91 7/15/20235,330,000 shares $52.07 million +6.6%10.3%6 $9.77 6/30/20235,000,000 shares $42.50 million -14.2%9.7%5.6 $8.50 6/15/20235,830,000 shares $48.16 million +2.3%11.3%7.1 $8.26 5/31/20235,700,000 shares $45.49 million -8.1%11.0%6.7 $7.98 5/15/20236,200,000 shares $51.71 million +19.2%12.0%4.5 $8.34 4/30/20235,200,000 shares $42.07 million +1.6%10.0%3.8 $8.09 4/15/20235,120,000 shares $45.47 million -0.2%9.9%3.7 $8.88 3/31/20235,130,000 shares $46.89 million +0.6%9.9%3.7 $9.14 3/15/20235,100,000 shares $50.39 million +4.5%9.9%3.6 $9.88 2/28/20234,880,000 shares $82.08 million -1.0%9.4%3.5 $16.82 2/15/20234,930,000 shares $77.35 million -2.6%9.5%5.3 $15.69 1/31/20235,060,000 shares $75.60 million +2.2%9.8%4.9 $14.94 1/15/20234,950,000 shares $70.49 million +3.6%N/A4.8 $14.24 12/30/20224,780,000 shares $54.54 million +43.5%N/A4.7 $11.41 12/15/20223,330,000 shares $41.79 million -26.0%N/A3.3 $12.55 11/30/20224,500,000 shares $58.28 million -1.8%N/A4.7 $12.95 11/15/20224,580,000 shares $63.25 million -5.2%N/A4.9 $13.81 10/31/20224,830,000 shares $96.17 million +3.0%N/A5.7 $19.91 10/15/20224,690,000 shares $77.15 million -1.1%N/A5.6 $16.45 9/30/20224,740,000 shares $80.67 million +21.9%N/A5.8 $17.02 9/15/20223,890,000 shares $72.59 million +7.2%N/A4.9 $18.66 8/31/20223,630,000 shares $71.11 million +1.1%N/A4.4 $19.59His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. CDNA Short Interest - Frequently Asked Questions What is CareDx's current short interest? Short interest is the volume of CareDx shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 4,690,000 shares of CDNA short. 9.54% of CareDx's shares are currently sold short. Learn More on CareDx's current short interest. What is a good short interest ratio for CareDx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDNA shares currently have a short interest ratio of 5.0. Learn More on CareDx's short interest ratio. What is a good short interest percentage for CareDx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.54% of CareDx's floating shares are currently sold short. Is CareDx's short interest increasing or decreasing? CareDx saw a decrease in short interest in April. As of April 15th, there was short interest totaling 4,690,000 shares, a decrease of 9.5% from the previous total of 5,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CareDx's float size? CareDx currently has issued a total of 51,780,000 shares. Some of CareDx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CareDx currently has a public float of 49,140,000 shares. How does CareDx's short interest compare to its competitors? 9.54% of CareDx's shares are currently sold short. Here is how the short interest of companies compare to CareDx: Celcuity Inc. (6.08%), Sera Prognostics, Inc. (1.32%), Castle Biosciences, Inc. (5.32%), Fulgent Genetics, Inc. (3.12%), Genetron Holdings Limited (0.08%), Biodesix, Inc. (0.27%), Burning Rock Biotech Limited (0.47%), Personalis, Inc. (2.62%), Viridian Therapeutics, Inc. (15.50%), Veracyte, Inc. (4.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short CareDx stock? Short selling CDNA is an investing strategy that aims to generate trading profit from CareDx as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CareDx? A short squeeze for CareDx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CDNA, which in turn drives the price of the stock up even further. How often is CareDx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDNA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Celcuity Short Interest Sera Prognostics Short Interest Castle Biosciences Short Interest Fulgent Genetics Short Interest Genetron Short Interest Biodesix Short Interest Burning Rock Biotech Short Interest Personalis Short Interest Viridian Therapeutics Short Interest Veracyte Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CDNA) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry